Nymox Pharmaceutical Corp. Faces $716,000 Loss in Q3
Nymox Pharmaceutical Corp. announces a Q3 loss of $716,000, highlighting challenges in the pharmaceutical sector. Explore the financial implications.
Topic
Pharmaceutical Loss
A collection of 1 issue